NCT00272480View on ClinicalTrials.gov

Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 8, 1999

Primary Completion Date

July 30, 2002

Study Completion Date

July 30, 2002

Conditions
HTLV-I-associated Myelopathy
Interventions
DRUG

Zidovudine/lamivudine

DRUG

Placebos

Trial Locations (1)

W2 1PG

Imperial College, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT00272480 - Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial | Biotech Hunter | Biotech Hunter